Results 231 to 240 of about 12,626,738 (303)
Abstract Introduction In border regions like the EuRegio Meuse‐Rhine (EMR), mobility does not stop at the border. HIV risk may therefore not only be determined by within‐country factors but also by between‐country differences. We explored between‐country differences in HIV indicators in the EMR using two complementary data‐driven approaches.
Hanne M. L. Zimmermann +9 more
wiley +1 more source
Immunogenicity and safety of co-administered <i>Escherichia coli</i>-produced bivalent HPV-16/18 vaccine and hepatitis E vaccine. [PDF]
Yan R +11 more
europepmc +1 more source
ABSTRACT Background Hepatocellular carcinoma (HCC) remains one of the leading causes of cancer‐related deaths in Malaysia. Early detection increases the likelihood of curative treatment and improves survival. This consensus document aims to provide evidence‐based, locally relevant recommendations for the prevention and early detection of HCC.
Su Yin Lau +18 more
wiley +1 more source
Immunization Gaps Among High-Risk Preterm Infants in Kazakhstan. [PDF]
Tatibekova BN +3 more
europepmc +1 more source
A bibliometric analysis of immunotherapy for chronic hepatitis B: trends and hotspots prediction. [PDF]
Jin X, Tang Y, Ma Y, Li M, Gao Y.
europepmc +1 more source
Emerging antiviral drugs and immunotherapy for chronic hepatitis B and associated liver disease. [PDF]
Zhu C, Yang J, Sheng Y, Fang M.
europepmc +1 more source
Vaccination Coverage and Prevention Counselling for Vaccine-Preventable STIs Among HIV PrEP Users in São Paulo, Brazil: A Retrospective Cohort Study. [PDF]
Rapozo MM +6 more
europepmc +1 more source
Challenges and achievements on the road to hepatitis elimination. [PDF]
europepmc +1 more source
From Jenner to genomics: the unfolding future of vaccinology. [PDF]
Batool R.
europepmc +1 more source

